P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

about

Purinergic Signalling: Therapeutic Developments.Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling.

P2860

Q42367885-32FEF2DC-BF70-47A8-B19D-12A9A98B5630 Q54988313-1AB2030F-D122-4DEA-A8CD-29D3C61D962B

P2860

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

Item

http://www.wikidata.org/entity/Q38420789

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

@en

type

Item

label

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

@en

prefLabel

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

@en

P1476

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

@en

P2093

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Paul A Gurbel

http://www.w3.org/2001/XMLSchema#string

Udaya S Tantry

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Thrombolysis in acute stroke patients with cerebral small vessel disease

Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010

Cause and mechanisms of intracranial atherosclerosis

Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial

Antiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectives

P304

1149-1165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1035256

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25873127

http://www.w3.org/2001/XMLSchema#string

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

about

P2860

P2860

P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698